BridgeMD
New treatment option for Chronic Spinal Pain
Official title RTMS and Steroid Joint Steroid Injection in Chronic Spinal Pain
ClinicalTrials.gov ID: NCT05840354
What this study is testing
- What it's testing
- Chronic spinal pain (CSP) is one of the most common chronic pain conditions globally. Steroid joint injections (SJI) are a routine treatment option for patients with CLBP that is recalcitrant to other treatments.
- You might receive a placebo (an inactive treatment) instead of the study drug, decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Currently receiving recurrent steroid joint injections for control of chronic spinal pain at the St. Joseph's Health Centre Pain Clinic in London...
- Have pain in the spinal region of an intensity ≥4 out of 10 in the week before your most recent steroid joint injection,
- Have received at least 2 steroid joint injections within the last 12 months at regular intervals
- Have had a consistent medication regimen for the past 3 months.
You likely can't join if
- Unable to read, understand, and speak English and are not able to give consent
- Known or suspected serious spinal pathology (tumour, fracture, dislocation, scoliosis)
- Spinal surgery in the past 12 months
- History of uncontrolled mental health condition(s)
- Meet any specific rTMS-related exclusion criteria listed on the safety screening questionnaire (S1; Rossi et al., 2008).
The study team makes the final eligibility decision.
Where it's taking place
- London, Ontario, Canada
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include London, Ontario, Canada. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.